155 related articles for article (PubMed ID: 25243012)
1. Successful use of long acting octreotide in two cases with Beckwith-Wiedemann syndrome and severe hypoglycemia.
Al-Zubeidi H; Gottschalk ME; Newfield RS
Int J Pediatr Endocrinol; 2014; 2014(1):18. PubMed ID: 25243012
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic surgery in infants with Beckwith-Wiedemann syndrome and hyperinsulinism.
Laje P; Palladino AA; Bhatti TR; States LJ; Stanley CA; Adzick NS
J Pediatr Surg; 2013 Dec; 48(12):2511-6. PubMed ID: 24314195
[TBL] [Abstract][Full Text] [Related]
3. Congenital hyperinsulinism in an infant with paternal uniparental disomy on chromosome 11p15: few clinical features suggestive of Beckwith-Wiedemann syndrome.
Adachi H; Takahashi I; Higashimoto K; Tsuchida S; Noguchi A; Tamura H; Arai H; Ito T; Masue M; Nishibori H; Takahashi T; Soejima H
Endocr J; 2013; 60(4):403-8. PubMed ID: 23197114
[TBL] [Abstract][Full Text] [Related]
4. Hepatoblastoma and Wilms' tumour in an infant with Beckwith-Wiedemann syndrome and diazoxide resistant congenital hyperinsulinism.
Uppal S; Blackburn J; Didi M; Shukla R; Hayden J; Senniappan S
Endocrinol Diabetes Metab Case Rep; 2019 Feb; 2019():. PubMed ID: 30817313
[TBL] [Abstract][Full Text] [Related]
5. Hypopituitarism in a patient with Beckwith-Wiedemann syndrome due to hypomethylation of KvDMR1.
Baiocchi M; Yousuf FS; Hussain K
Pediatrics; 2014 Apr; 133(4):e1082-6. PubMed ID: 24639276
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of congenital hyperinsulinism with long-acting release octreotide.
Le Quan Sang KH; Arnoux JB; Mamoune A; Saint-Martin C; Bellanné-Chantelot C; Valayannopoulos V; Brassier A; Kayirangwa H; Barbier V; Broissand C; Fabreguettes JR; Charron B; Thalabard JC; de Lonlay P
Eur J Endocrinol; 2012 Feb; 166(2):333-9. PubMed ID: 22048969
[TBL] [Abstract][Full Text] [Related]
7. Late Presentation of Fulminant Necrotizing Enterocolitis in a Child with Hyperinsulinism on Octreotide Therapy.
Hawkes CP; Adzick NS; Palladino AA; De León DD
Horm Res Paediatr; 2016; 86(2):131-136. PubMed ID: 26867223
[TBL] [Abstract][Full Text] [Related]
8. Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p.
Zarate YA; Shur N; Robin A; Garnica AD; Quintos JB; Schaefer GB
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):951-5. PubMed ID: 24756053
[TBL] [Abstract][Full Text] [Related]
9. Rare association of Beckwith-Wiedemann syndrome with Hirschsprung's disease in an infant with hypoglycemia.
Shah N; Khadilkar A; Khadilkar V; Lad S
BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32341092
[TBL] [Abstract][Full Text] [Related]
10. Octreotide-LAR is a Useful Alternative for the Management of Diazoxide-Responsive Congenital Hyperinsulinism.
Karlekar MP; Sarathi V; Arya S; Flanagan SE; Patil V; Lila A; Shah N; Bandgar T
Horm Metab Res; 2021 Nov; 53(11):723-729. PubMed ID: 34740273
[TBL] [Abstract][Full Text] [Related]
11. Hyperinsulinemic hypoglycemia in Beckwith-Wiedemann syndrome due to defects in the function of pancreatic beta-cell adenosine triphosphate-sensitive potassium channels.
Hussain K; Cosgrove KE; Shepherd RM; Luharia A; Smith VV; Kassem S; Gregory JW; Sivaprasadarao A; Christesen HT; Jacobsen BB; Brusgaard K; Glaser B; Maher EA; Lindley KJ; Hindmarsh P; Dattani M; Dunne MJ
J Clin Endocrinol Metab; 2005 Jul; 90(7):4376-82. PubMed ID: 15811927
[TBL] [Abstract][Full Text] [Related]
12. Poor pregnancy outcome after octreotide treatment during pregnancy for familial hyperinsulinemic hypoglycemia: a case report.
Skajaa GO; Mathiesen ER; Iyore E; Beck-Nielsen H; Jimenez-Solem E; Damm P
BMC Res Notes; 2014 Nov; 7():804. PubMed ID: 25404386
[TBL] [Abstract][Full Text] [Related]
13. Genetic characteristics of patients with congenital hyperinsulinism.
Vajravelu ME; De León DD
Curr Opin Pediatr; 2018 Aug; 30(4):568-575. PubMed ID: 29750770
[TBL] [Abstract][Full Text] [Related]
14. Hyperinsulinemic hypoglycemia in Beckwith-Wiedemann, Sotos, and Kabuki syndromes: A nationwide survey in Japan.
Toda N; Ihara K; Kojima-Ishii K; Ochiai M; Ohkubo K; Kawamoto Y; Kohno Y; Kumasaka S; Kawase A; Ueno Y; Futatani T; Miyazawa T; Nagaoki Y; Nakata S; Misaki M; Arai H; Kawai M; Sato M; Yada Y; Takahashi N; Komatsu A; Maki K; Watabe S; Sumida Y; Kuwashima M; Mizumoto H; Sato K; Hara T
Am J Med Genet A; 2017 Feb; 173(2):360-367. PubMed ID: 28102591
[TBL] [Abstract][Full Text] [Related]
15. Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon.
Mohnike K; Blankenstein O; Pfuetzner A; Pötzsch S; Schober E; Steiner S; Hardy OT; Grimberg A; van Waarde WM
Horm Res; 2008; 70(1):59-64. PubMed ID: 18493152
[TBL] [Abstract][Full Text] [Related]
16. Hyperinsulinemic Hypoglycemia in a Patient with Costello Syndrome: An Etiology to Consider in Hypoglycemia.
Vuralli D; Kosukcu C; Taskiran E; Simsek-Kiper PO; Utine GE; Boduroglu K; Alikasifoglu A; Alikasifoglu M
Mol Syndromol; 2020 Nov; 11(4):207-216. PubMed ID: 33224014
[TBL] [Abstract][Full Text] [Related]
17. The effects of a somatostatin analogue on the metabolism of an infant with Beckwith-Wiedemann syndrome and hyperinsulinaemic hypoglycaemia.
Gerver WJ; Menheere PP; Schaap C; Degraeuwe P
Eur J Pediatr; 1991 Jul; 150(9):634-7. PubMed ID: 1915515
[TBL] [Abstract][Full Text] [Related]
18. [Long-term diazoxide therapy of the Beckwith-Wiedemann syndrome with persistent hypoglycemia].
Santucci S; Tosi M; Marazzini P; Barp S; Bertoletti A
Minerva Pediatr; 1982 Sep; 34(17):721-3. PubMed ID: 7144714
[No Abstract] [Full Text] [Related]
19. Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion.
Rouland A; Bouillet B; Legris P; Simoneau I; Petit JM; Vergès B
Clin Pharmacol; 2021; 13():33-37. PubMed ID: 33574715
[TBL] [Abstract][Full Text] [Related]
20. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses.
Boyle PJ; Justice K; Krentz AJ; Nagy RJ; Schade DS
J Clin Endocrinol Metab; 1993 Mar; 76(3):752-6. PubMed ID: 8445035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]